Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-requlated osteoclast differentiation

Journal of Clinical Investigation

Volumn 114, Issue 4, 2004, Pages 475-484

  Ikeda, Fumiyo ^a   Nishimura, Riko ^a   Matsubara, Takuma ^a   Tanaka, Sakae ^b   Inoue, Jun Ichiro ^b   Reddy, Sakamuri V ^c   Hata, Kenji ^a   Yamashita, Kenji ^a   Hiraga, Toru ^a   Watanabe, Toshiyuki ^d   Kukita, Toshio ^d   Yoshioka, Katsuji ^e   Rao, Anjana ^f   Yoneda, Toshiyuki ^a  

^a OSAKA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^d KYUSHU UNIVERSITY   (Japan)

^e KANAZAWA UNIVERSITY   (Japan)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR; PHOSPHATASE; STRESS ACTIVATED PROTEIN KINASE; TARTARIC ACID; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT1; TRANSCRIPTION FACTOR NFAT2; UNCLASSIFIED DRUG; ANTHRA(1,9 CD)PYRAZOL 6(2H) ONE; ANTHRA(1,9-CD)PYRAZOL-6(2H)-ONE; ANTHRACENE DERIVATIVE; CARRIER PROTEIN; DNA BINDING PROTEIN; MEMBRANE PROTEIN; NFATC1 PROTEIN, MOUSE; NFATC2 PROTEIN, MOUSE; NUCLEAR PROTEIN; PROTEIN C JUN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TNFRSF11A PROTEIN, MOUSE; TNFSF11 PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; DISEASE SEVERITY; GENE ACTIVATION; GENE OVEREXPRESSION; MOUSE; NEWBORN; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FAMILY; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSGENIC MOUSE; ADENOVIRUS; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CELL LINE; CELL STRAIN COS1; CERCOPITHECUS; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MONOCYTE; OSTEOCLAST; PATHOLOGY; REPORTER GENE; TRANSACTIVATION;

ADENOVIRIDAE; ANIMALS; ANIMALS, NEWBORN; ANTHRACENES; BONE MARROW CELLS; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; CERCOPITHECUS AETHIOPS; COS CELLS; DNA-BINDING PROTEINS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENES, REPORTER; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MONOCYTES; NFATC TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; OSTEOCLASTS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-JUN; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 4344697340     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200419657     Document Type: Article

References (41)

1. Suda, T., et al. 1999. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20:345-357.
2. Teitelbaum, S.L. 2000. Bone resorption by osteoclasts. Science. 289:1504-1508.
3. Wagner, E.F., and Karsenty, G. 2001. Genetic control of skeletal development. Curr. Opin. Genet. Dev. 11:527-532.
4. Yasuda, H., et al. 1998. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. U. S. A. 95:3597-3602.
5. Kong, Y.Y., et al. 1999. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 397:315-323.
6. Li, J., et al. 2000. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc. Natl. Acad. Sci. U. S. A. 97:1566-1571.
7. Lomaga, M.A., et al. 1999. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 13:1015-1024.
8. Naito, A., et al. 1999. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells. 4:353-362.
9. Franzoso, G., et al. 1997. Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev. 11:3482-3496.
10. Matsumoto, M.; Sudo, T., Saito, T., Osada, H., and Tsujimoto, M. 2000. Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL). J. Biol. Chem. 275:31155-31161.
11. Kobayashi, N., et al. 2001. Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis. EMBO J. 20:1271-1280.
12. Grigoriadis, A.E., et al. 1994. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science. 266:443-448.
13. Johnson, R.S., van Lingen, B., Papaioannou, V.E., and Spiegelman, B.M. 1993. A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth inculture. Genes Dev. 7:1309-1317.
14. Dong, Z., et al. 1996. AP-1/jun is required for early Xenopus development and mediates mesoderm induction by fibroblast growth factor but not by activin. J. Biol. Chem. 271:9942-9946.
15. Lenczowski, J.M., et al. 1997. Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis. Mol. Cell. Biol. 17:170-181.
16. Reddy, S.V., et al. 1995. Characterization of the mouse tartrate-resistant acid phosphatase (TRAP) gene promoter. J. Bone Miner. Res. 10:601-606.
17. -/- mutant mice. Genes Dev. 11:2835-2844.
18. Kobayashi, K., et al. 2000. Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J. Exp. Med. 191:275-286.
19. Bennett, B.L., et al. 2001. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U. S. A. 98:13681-13686.
20. Macian, F., Lopez-Rodriguez, C., and Rao, A. 2001. Partners in transcription: NFAT and AP-1. Oncogene. 20:2476-2489.
21. Crabtree, G.R., and Olson, E.N. 2002. NFAT signaling: choreographing the social lives of cells [review]. Cell. 109(Suppl.):S67-S79.
22. Hogan, P.G., Chen, L., Nardone, J., and Rao, A. 2003. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 17:2205-2232.
23. Aramburu, J., et al. 1999. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science. 285:2129-2133.
24. Ishida, N., et al. 2002. Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J. Biol. Chem. 277:41147-41156.
25. Takayanagi, H., et al. 2002. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell. 3:889-901.
26. Zheng, C., Xiang, J., Hunter, T., and Lin, A. 1999. The JNKK2-JNK1 fusion protein acts as a constitutively active c-Jun kinase that stimulates c-Jun transcription activity. J. Biol. Chem. 274:28966-28971.
27. Zhou, B., et al. 2002. Regulation of the murine Nfatc1 gene by NFATc2. J Biol. Chem. 277:10704-10711.
28. Kiani, A., Rao, A., and Aramburu, J. 2000. Manipulating immune responses with immunosuppressive agents that target NFAT. Immunity. 12:359-372.
29. 2+ accelerates nuclear translocation of nuclear factor kappa B in osteoclasts. J. Biol. Chem. 278:8286-8293.
30. Koga, T., et al. 2004. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature. 428:758-763.
31. Moitra, J., et al. 1998. Life without white fat: a transgenic mouse. Genes Dev. 12:3168-3181.
32. Hedin, K.E., et al. 1997. δ-opioid receptors expressed by Jurkat T cells enhance IL-2 secretion by increasing AP-1 complexes and activity of the NF-AT/AP-1-binding promoter element. J. Immunol. 159:5431-5440.
33. Macian, F., et al. 2002. Transcriptional mechanisms underlying lymphocyte tolerance. Cell. 109:719-731.
34. Ito, M., et al. 1999. JSAP1, a novel jun N-terminal protein kinase (JNK)-binding protein that functions as a scaffold factor in the JNK signaling pathway. Mol. Cell. Biol. 19:7539-7548.
35. Monzen, K., et al. 2001. Smads, TAK1, and their common target ATF-2 play a critical role in cardiomyocyte differentiation. J. Cell Biol. 153:687-698.
36. Nishimura, R., et al. 1998. Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12. J. Biol. Chem. 273:1872-1879.
37. Nishimura, R., Hata, K., Harris, S.E., Ikeda, F., and Yoneda, T. 2002. Core-binding factor α1-(Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5. Bone. 31:303-312.
38. Hata, K., et al. 2003. Differential roles of Smad1 and p38 kinase in regulation of peroxisome proliferator-activating receptor γ during bone morphogenetic protein 2-induced adipogenesis. Mol. Biol. Cell. 14:545-555.
39. Miyake, S., et al. 1996. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc. Natl. Acad. Sci. U. S. A. 93:1320-1324.
40. Morita, S., Kojima, T., and Kitamura, T. 2000. PlatE: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7:1063-1066.
41. Deng, Y., Ren, X., Yang, L., Lin, Y., and Wu, X. 2003. A JNK-dependent pathway is required for TNFα-induced apoptosis. Cell. 115:61-70.